Report of Henoch-Schönlein purpura associated with trastuzumab emtansine

30 Jul 2024

Santiago Leandro Escobar-Dávila, Giovanna Patricia Rivas-Tafurt, Luis Álvaro Melo-Burbano, Luis Miguel Osorio-Toro, Edith Norela Benítez-Escobar, Duván Arley Galindes-Casanova, Jorge Hernán Izquierdo-Loaiza, Rodrigo Andrés Cárdenas-Perilla, Carlos Orozco-de la Hoz

Vasculitides are a set of pathologies that can affect one or several organs, in the short and long term. They are associated with various etiologies, among which paraneoplastic syndromes and medications stand out. Although everyday cancer therapies are more directed against a therapeutic target, their use can cause a wide spectrum of complications. Some treatments against human epidermal growth factor 2 (HER2) have been associated with cutaneous and pulmonary vasculitis. We present the first case of Henoch-Schönlein purpura associated with the use of T-DM1 in a patient with HER2 breast cancer.

2071-the-global-cancer-crisis-a-review-of-growing-burden-deepening-inequality-and-initiatives-for-prevention-and-early-detection

Review: The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection

Charles M Balch, Ning Liao, Denis S C Lam, Jeffrey N Weitzel, Rui-Hua Xu, Gerhardt Attard, Paul A Bunn, Alexander M M Eggermont, Jie He, Yuko Kitagawa, Soon Thye Lim, Eduardo Cazap, Bernard Esquivel, Xianqun Fan, Louis W C Chow, Edward S F Liu, Hector Martinez Said, John E Niederhuber, Isabel T Rubio, Ashraf Saad Zaghloul, Oscar G Arrieta, Riccardo A Audisio, Geerard L Beets, Felipe J F Coimbra, Jorge E Gallardo, Judy E Garber, Alessandro Gronchi, Volker Heinemann, Allison W Kurian, Miriam Mutebi, Masaki Mori, Funmi I Olopade, Piotr Rutkowski, Mansoor Saleh, William M Sanchez, Raymond Sawaya, John F Thompson, Gerald Tumusiime, Carlos S Vallejos, David C Whiteman, YiLong Wu, King-David T Yawe, Nayef Awad Al Zahrani, Odysseas Zoras, Banu K Arun, Carol J Fabian, Jeffrey E Gershenwald, William J Gradishar, Jin He, V Suzanne Kimberg, Ronald M K Lam, Victor H F Lee, Domenica Lorusso, Tony S K Mok, N D Perrier, Hope S Rugo, Cornelia Ulrich, Chandrakanth Are

3 Feb 2026

https://doi.org/10.3332/ecancer.2026.2071

Abstract | Full Article | PDF

2069-navigating-social-networks-in-cancer-care-a-phenomenological-exploration-of-patient-experiences

Research: Navigating social networks in cancer care: a phenomenological exploration of patient experiences

Yousef Roosta, Hero Khezri, Vahid Hoseinpour, Mohamad Jebraeily, Amirhossein Rayegani, Saeed Razavi-Dizaji

30 Jan 2026

https://doi.org/10.3332/ecancer.2026.2069

Abstract | Full Article | PDF

2070-locally-advanced-breast-cancer-is-the-number-of-dissected-nodes-after-neoadjuvant-chemotherapy-important

Review: Locally advanced breast cancer is the number of dissected nodes after neoadjuvant chemotherapy important?

Josepmilly Del Valle Peña Colmenares, Wladimir José Villegas Rodríguez, Osama Bahsas Zaky, Carlos Eduardo Martínez, Douglas José Angulo Herrera

30 Jan 2026

https://doi.org/10.3332/ecancer.2026.2070

Abstract | Full Article | PDF

2065-barriers-and-facilitators-of-adoption-and-implementation-of-a-financial-navigation-program-cost-fin-trial

Research: Barriers and facilitators of adoption and implementation of a financial navigation program: cost-fin trial

Adewale Isaiah Oyewole, Funmilola Olanike Wuraola, Amir H Sohail, Titilope Ogunniyi, Chinyere Nwankwo, Zainab Oyindamola Adegbite, Dorcas Olaide Ebekue, Clement D Awe, Elizabeth N Christian, Kristina Diaz, Oluwasegun Afolaranmi, Clara N Lambert, Dan Sherman, George Gutierrez, Chinenye Iwuji, Juliet S Lumati

22 Jan 2026

https://doi.org/10.3332/ecancer.2026.2065

Abstract | Full Article | PDF